1TOYING WITH Children's Health: 2007 was a tough year for children's health. Millions of toys were taken from babies' hands after being found to contain lead paint. Thousands of dolls and play sets were recalled because their defective designs allowed detachable magnets to become swallowing and choking hazards. At least...
Drug maker GlaxoSmithKline PLC said it will close its plant in Cidra, opened in 196, due to declining sales of drugs including the diabetes treatment Avandia, reports AP (Oct. 24, 2007). The company will transfer production of Avandia and the related drug Avandamet to other facilities...
WASHINGTON AFP — An analysis of four clinical trials involving more than 14,000 patients found that diabetes medication Avandia rosiglitazone taken over a lengthy period of time increases the risk of heart attack by 42 percent, a report released Tuesday said. It marks one of the first studies to...
To: MEDICAL EDITORSContact: Susan Herold of Consumer Reports Best Buy Drugs, +1-202- 462-6262 WASHINGTON, July 16 /PRNewswire-USNewswire/ -- Newer prescription drugs to treat type 2 diabetes -- including much-promoted Avandia and Actos -- are no more effective or safe than older drugs and cost significantly more, according to the latest...
WASHINGTON -- Safety concerns about a GlaxoSmithKline diabetes drug prompted some Democratic lawmakers on Wednesday to rebuke the Food and Drug Administration and call for increased regulation of the pharmaceutical industry. The controversy surrounding Glaxo's Avandia intensified when a medical expert told Congress that executives threatened to...
WASHINGTON AFP — Controversy over diabetes drug Avandia heated up Wednesday as experts pointed to studies linking it to greater heart attack risk, while a GSK study claimed rosiglitazone is safe. The GlaxoSmithKline study published online Tuesday by the New England Journal of Medicine NEJM gave preliminary results of...
Many people with type 2 diabetes are wondering whether to keep taking their medication now that a new report suggests Avandia, a pill widely used to help control blood sugar, can raise heart attack risk. As of Tuesday afternoon, the American Diabetes Association had fielded 70...
Personal-injury lawsuits against GlaxoSmithKline Plc over its top- selling diabetes drug Avandia will be consolidated in a federal court in Philadelphia, a panel of judges concluded. The decision by the seven-member Judicial Panel of Multi-District Litigation came after lawyers argued last month in New York over the appropriate court for...
A group of Chinese generic drug manufacturers, believed to include Shanghai Sunve and Chongqing Taiji, are to dispute GlaxoSmithKline's patent for diabetes drug Avandia. A State Intellectual Property Office hearing is set for 18 August - analysts th A group of Chinese generic drug manufacturers,...
GlaxoSmithKline GSK unveiled strong third-quarter results, with EPS up 20 per cent on the year to 21.3p, boosted by disposal gains. Pharmaceutical sales at the UK's largest drug company rose by 10 per cent to GBP4.7bn, with growth strong in the Adv GlaxoSmithKline GSK unveiled strong...
Well before Vytorin became a cause célèbre -- which is to say, about a year ago -- GlaxoSmithKline was the drugmaker getting slapped around by critics for downplaying or ignoring possible heart problems associated with its diabetes drug Avandia. That case, which led to new warnings on the drug's label...
MEntertainment Rights 1.25p (down 0.65p, 34.21 per cent) Heading for second breach of covenants this month. MAstraZeneca 2,630p (up 80p, 3.14 per cent) Dresdner Kleinwort raises target price from 2,780p to 2930p. MShire 819p (up 35.50p, 4.53 per cent) JP Morgan lifts price target...
PHILADELPHIA, Oct. 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline today issued the following response to a petition filed by Public Citizen to the U.S. Food and Drug Administration FDA on AVANDIAR rosiglitazone maleate, a highly effective therapy for treating type 2 diabetes when used in the appropriate patient population. ...
LONDON AFP — British pharmaceutical giant GlaxoSmithKline said Wednesday that third-quarter net profits sank heavily owing partly to increased competition from generic drugmakers. Net profits dived 21.6 percent to 1.03 billion pounds (1.31 billion euros, 1.68 billion dollars) in the three months to the end of September, compared...
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: GlaxoSmithKline Plc. (NYSE: GSK), Metabasis Therapeutics, Inc. (Nasdaq: MBRX), Central Garden...
TWO DIABETES product sites, Merck's Januvia and Takeda's Actos, came in first and second, respectively, in a new study measuring physicians' web habits. The study, conducted by Manhattan Research, ranked drug product sites based on visitation rates from physicians. Merck had the most products on the list, at three,...
The FDA has updated the label for Avandia to include findings demonstrating sustained glycemic control for up to five years. GlaxoSmithKline PLC markets the diabetes treatment, which is also known as rosiglitazone maleate...
A wrongful death suit was filed againstGlaxoSmithKline, SmithKline Beecham, and McKesson Corporation in CaliforniaSuperior Court, charging that Avandia, prescribed for Type 2 Diabetes, ledto heart attacks, congestive heart failure and other fatal cardiovascularinjuries in seven individuals. The suit, brought by Khorrami, Pollard & Abir and Kabateck Brown Kellner,LLP, was filed...
LONDON AFP — British pharmaceutical giant GlaxoSmithKline said on Wednesday that net profits slipped during the second quarter owing to competition from generic drugmakers and poor sales of diabetes drug Avandia. GSK's new chief executive Andrew Witty used his maiden results to unveil a major strategy overhaul aimed...
